МІЛРОН

ਉਤਪਾਦ ਝਲਕ

About МІЛРОН

МІЛРОН is a medication containing the active ingredient Milrinone, a phosphodiesterase 3 inhibitor. It is used in the treatment of acute decompensated heart failure and as a bridge to cardiac transplantation or other therapies.

Key Benefits & Uses

• Treatment of acute decompensated heart failure
• Bridge to cardiac transplantation or other therapies
• Improvement of cardiac output and reduction of pulmonary capillary wedge pressure

Active Ingredient & Action

Milrinone works by inhibiting phosphodiesterase 3, an enzyme that breaks down cyclic adenosine monophosphate (cAMP) in the heart. By increasing cAMP levels, Milrinone enhances cardiac contractility, reduces systemic vascular resistance, and improves cardiac output.

Important Notes

МІЛРОН should be used under the guidance of a healthcare professional. It is essential to monitor patients for potential side effects, such as hypotension, tachycardia, and arrhythmias. Patients with a history of hypersensitivity to Milrinone or other phosphodiesterase inhibitors should not use this medication.